Results 201 to 210 of about 262,635 (315)

Flow cytometry CD4+/CD8+ ratio of liver-derived lymphocytes correlates with viral replication in chronic hepatitis B [PDF]

, 1994
B‐N. Pham, Jean‐François Mosnier, Francine Walker, Corinne Njapoum, F. Bougy, Claude Degott, Serge Erlinger, J. Cohen, Françoise Degos   +8 more
openalex   +1 more source

Exploring the Potential and Advancements of Circular RNA Therapeutics

Exploration, EarlyView.
Given the remarkable advantages in terms of stability, sustained expression profile, safety, wide range of druggable targets, scalable and cost‐effective manufacturing capabilities, circRNA is currently undergoing intensive investigation for various therapeutic applications such as vaccines, protein replacement, genetic disease treatment, gene therapy,
Lei Wang, Lianqing Wang, Chunbo Dong, Jialong Liu, Guoxin Cui, Shan Gao, Zhida Liu   +6 more
wiley   +1 more source

Tenofovir amibufenamide: A potential alternative for chronic hepatitis B treatment. [PDF]

World J Gastroenterol
Ma HN, Cao KS, Liu YM, Chen C, Zhang H, Tang FS.   +5 more
europepmc   +1 more source

Clinical significance of low molecular weight (7–8s) immunoglobulin M antibody to hepatitis B core antigen in chronic hepatitis B virus infections

, 1986
Maria H. Sjögren, William H. Bancroft, Jay H. Hoofnagle, James L. Sosebee, Stanley M. Lemon   +4 more
openalex   +1 more source

Effects of recombinant alpha interferon on chronic active hepatitis B: preliminary results. [PDF]

, 1993
Yusuf Bayraktar, B Uzunalimoğlu, Serkan Arslan, Tankut Köseoğlu, B Kayhan, H Telatar   +5 more
openalex   +1 more source

Emerging Target Discovery Strategies Drive the Decoding of Therapeutic Power of Natural Products and Further Drug Development: A Case Study of Celastrol

Exploration, EarlyView.
Using celastrol as a case study, this review summarizes various target discovery strategies for natural products, including chemical proteomics, protein microarray, degradation‐based protein profiling, proteome‐wide label‐free approaches, network pharmacology, target‐based drug screening, and indirect strategies.
Yanbei Tu, Guiyu Dai, Yanyan Chen, Lihua Tan, Hanqing Liu, Meiwan Chen   +5 more
wiley   +1 more source

Evaluation of HBsAg and HBeAg seroconversion rates in patients diagnosed with chronic hepatitis B: A 10-year retrospective analysis. [PDF]

Saudi Med J
Toygar Deniz M, Fatih Karaşın M, Asena Doğan Öntaş İ, Akhan S.   +3 more
europepmc   +1 more source

Levamisole and interferon in children with chronic hepatitis B [PDF]

, 1993
M Ruíz-Moreno
openalex   +1 more source

Food Toxicology and Safety: Evaluating Dietary Risks and Functional Ingredients

Food Bioengineering, EarlyView.
The pyramid's foundation reminds us that true health begins with daily habits—engage in 30–60 min of physical activity, nurture social connections and secure 7–9 h of restorative sleep each night to support metabolism, mood regulation, and hormonal balance—while continuously hydrating with 8–12 glasses of water and unsweetened herbal infusions (green ...
Sujaritha Jayaraj, Lavanya Kothandan, Vijay Babu Murugan, Saravana Kumar Prakash, Vandhana Vijayakumar, Elizabeth Rani   +5 more
wiley   +1 more source

Prevalence of low-level viremia in the treatment of chronic hepatitis B in China: a systematic review and meta-analysis. [PDF]

BMJ Open
Xie L, Liu G, Liu Y, Li P, Guo H.
europepmc   +1 more source